944 top medical experts on Antiphospholipid Syndrome across 59 countries and 35 U.S. states, including 809 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Antiphospholipid Syndrome: The presence of antibodies directed against phospholipids (antibodies, antiphospholipid). The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies (antibodies, anticardiolipin). Present also are high levels of lupus anticoagulant (lupus coagulation inhibitor).
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Autoimmune Diseases (3,976).
  4. Clinical Trials ClinicalTrials.gov : at least 77 including 2 Active, 30 Completed, 19 Recruiting


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Tincani, Angela   Google Publications
    Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Science, 18515ASST-Spedali Civili and University of Brescia, Brescia, Italy.
    Scientist  Highly Cited  Highly Published  Guideline  Clinical Trial  Case Reports  Review 
    Subjects: Pregnancy Complications; Antibodies, Antiphospholipid; Lupus Erythematosus, Systemic; Thrombosis; Anticoagulants
    Categories: Immunology; Epidemiology; Therapeutic Use; Blood; Diagnosis; Complications
    Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. (2018)
    EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. (2017)

  2. Meroni, Pier Luigi   Google Publications
    Department of Clinical Sciences and Community Health, 9304University of Milan, Milan, Italy.
    Scientist  Highly Cited  Highly Published  Guideline  Case Reports  Review 
    Subjects: Antibodies, Antiphospholipid; Thrombosis; Pregnancy Complications; Beta 2-Glycoprotein I; Lupus Erythematosus, Systemic
    Categories: Immunology; Diagnosis; Blood; Complications; Therapeutic Use; Drug Therapy
    EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. (2017)
    Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. (2015)

  3. Khamashta, Munther A   Google Publications
    2 The Lupus Clinic Rheumatology Department, Dubai Hospital, Dubai, United Arab Emirates.
    Scientist  Highly Cited  Highly Published  Guideline  Clinical Trial  Case Reports  Review 
    Subjects: Antibodies, Antiphospholipid; Lupus Erythematosus, Systemic; Thrombosis; Anticoagulants; Pregnancy Complications
    Categories: Immunology; Therapeutic Use; Drug Therapy; Diagnosis; Blood; Complications
    EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. (2017)
    Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. (2015)

  4. Cervera, Ricard   Google Publications
    Department of Autoimmune Diseases, Hospital Clínic de Barcelona, Barcelona, Spain.
    Scientist  Highly Cited  Highly Published  Guideline  Case Reports  Review 
    Subjects: Thrombosis; Antibodies, Antiphospholipid; Lupus Erythematosus, Systemic; Pregnancy Complications; Anticoagulants
    Categories: Immunology; Complications; Drug Therapy; Blood; Diagnosis; Etiology
    EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. (2017)
    Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. (2015)

  5. Pengo, Vittorio   Google Publications
    Thrombosis Research Laboratory, Department of Cardio-Thoracic-Vascular Sciences and Public Health, University of Padua, Padua, Italy; Arianna Foundation on Anticoagulation, Bologna, Italy. Electronic address: .
    Scientist  Highly Cited  Highly Published  Guideline  Clinical Trial  Review 
    Subjects: Antibodies, Antiphospholipid; Thrombosis; Beta 2-Glycoprotein I; Lupus Coagulation Inhibitor; Anticoagulants
    Categories: Immunology; Blood; Diagnosis; Therapeutic Use; Epidemiology; Complications
    Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. (2018)
    Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies. (2011)

  6. Andreoli, Laura   Google Publications
    Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Science, 18515ASST-Spedali Civili and University of Brescia, Brescia, Italy.
    Scientist  Highly Cited  Highly Published  Guideline  Clinical Trial  Case Reports  Review 
    Subjects: Pregnancy Complications; Antibodies, Antiphospholipid; Lupus Erythematosus, Systemic; Thrombosis; Anticoagulants
    Categories: Immunology; Therapeutic Use; Diagnosis; Complications; Drug Therapy; Blood
    Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. (2018)
    EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. (2017)

  7. Salmon, Jane E   Rheumatology   ClinicalTrials.gov Google Publications
    Hospital for Special Surgery, 25062Weill Cornell Medicine, New York, NY, USA.
    Physician  Highly Cited  Highly Published  Case Reports 
    Relevant US NIH Grant Funding: $999,318 over the last 5 years
    Disclosed payments from biomedical company (UCB, Inc.) in 2021 for $1,725
    Subjects: Lupus Erythematosus, Systemic; Pregnancy Complications; Antibodies, Antiphospholipid; Trophoblasts; Beta 2-Glycoprotein I
    Categories: Immunology; Blood; Adverse Effects; Drug Therapy; Metabolism; Therapeutic Use
    Antiphospholipid syndrome. (2018)
    14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends. (2014)

  8. Ortel, Thomas L   Hematology   ClinicalTrials.gov Google Publications
    Duke University Medical Center, Durham, North Carolina. Top Hospital
    Physician  Highly Cited  Guideline 
    Disclosed payments in 2021 from 2 biomedical companies, totalling $2,350, including $1,500 from  Diagnostica Stago, Inc
    Subjects: Antibodies, Antiphospholipid; Advisory Committees; Biomedical Research; Cardiology; Congresses as Topic
    Categories: Immunology; Diagnosis; Standards; Blood; Drug Therapy; Analysis
    14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends. (2014)
    Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH. (2018)

  9. Erkan, Doruk   ClinicalTrials.gov Google Publications
    Barbara Volcker Center for Women and Rheumatic Disease, Hospital for Special Surgery, 25062Weill Cornell Medicine, New York, NY, USA.
    Scientist  Highly Cited  Highly Published  Clinical Trial  Case Reports  Review 
    Subjects: Antibodies, Antiphospholipid; Thrombosis; Lupus Erythematosus, Systemic; Anticoagulants; Hydroxychloroquine
    Categories: Immunology; Drug Therapy; Therapeutic Use; Blood; Complications; Diagnosis
    Diagnosis and Management of the Antiphospholipid Syndrome. (2018)
    Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies. (2011)

  10. Knight, Jason S   Rheumatology   Google Publications
    Division of Rheumatology, 1259University of Michigan, Ann Arbor, MI, USA.
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports 
    Relevant US NIH Grant Funding: $266,291 over the last 5 years
    Subjects: Antibodies, Antiphospholipid; Thrombosis; Neutrophils; Extracellular Traps; Anticoagulants
    Categories: Immunology; Drug Therapy; Blood; Etiology; Metabolism; Complications
    Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome. (2019)
    Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome. (2015)

  11. Tektonidou, Maria G   ClinicalTrials.gov Google Publications
    First Department of Propaedeutic Internal Medicine, Joint Academic Rheumatology Program, National and Kapodistrian University of Athens, Medical School, Athens, Greece. Electronic address: .
    Scientist  Highly Cited  Highly Published  Guideline  Clinical Trial  Review 
    Subjects: Antibodies, Antiphospholipid; Thrombosis; Lupus Erythematosus, Systemic; Pregnancy Complications; Kidney Diseases
    Categories: Blood; Immunology; Complications; Diagnosis; Drug Therapy; Etiology
    EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. (2017)
    Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. (2015)

  12. Sciascia, Savino   Google Publications
    Center of Research of Immunopathology and Rare Diseases- Coordinating Center of Piedmont and Aosta Valley Network for Rare Diseases, Department of Clinical and Biological Sciences, S. Giovanni Bosco Hospital, University of Turin, Piazza del Donatore di Sangue 3, 10154, Turin, Italy.
    Scientist  Highly Cited  Highly Published  Clinical Trial  Case Reports  Review 
    Subjects: Thrombosis; Antibodies, Antiphospholipid; Lupus Erythematosus, Systemic; Anticoagulants; Prothrombin
    Categories: Immunology; Diagnosis; Drug Therapy; Blood; Therapeutic Use; Complications
    Antiphospholipid syndrome. (2018)
    14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends. (2014)

  13. Lockshin, Michael D   Rheumatology   Google Publications
    Barbara Volcker Center for Women and Rheumatic Disease, Hospital for Special Surgery, 25062Weill Cornell Medicine, New York, NY, USA.
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports 
    Subjects: Antibodies, Antiphospholipid; Lupus Erythematosus, Systemic; Pregnancy Complications; Beta 2-Glycoprotein I; Antibodies, Anticardiolipin
    Categories: Blood; Immunology; Diagnostic Imaging; Therapeutic Use; Complications; Diagnosis
    14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends. (2014)
    Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. (2012)

  14. Ruffatti, Amelia   Google Publications
    Department of Medicine and.
    Scientist  Highly Cited  Highly Published  Clinical Trial  Case Reports 
    Subjects: Pregnancy Complications; Antibodies, Antiphospholipid; Aspirin; Thrombosis; Anticoagulants
    Categories: Therapeutic Use; Immunology; Blood; Therapy; Diagnosis; Drug Therapy
    Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. (2018)
    Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study. (2011)

  15. Bertolaccini, Maria Laura   Google Publications
    M.L. Bertolaccini, PhD, Academic Department of Vascular Surgery, Kings College London British Heart Foundation Centre of Excellence, School of Cardiovascular Medicine & Sciences, London, UK.
    Scientist  Highly Cited  Highly Published  Clinical Trial  Review 
    Subjects: Antibodies, Antiphospholipid; Thrombosis; Lupus Erythematosus, Systemic; Phosphatidylserines; Prothrombin
    Categories: Immunology; Diagnosis; Blood; Complications; Drug Therapy; Drug Effects
    Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. (2015)
    Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial. (2016)

  16. Streiff, Michael B   Hematology & Oncology  Google Publications
    Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. Top Hospital
    Physician  Case Reports 
    Medical school: Johns Hopkins University School of Medicine (MD, 1988)
    Medicare Accepted
    Disclosed payments from biomedical company (PFIZER INC.) in 2021 for $4,500
    Subjects: Acute Kidney Injury; Antibodies, Monoclonal, Humanized; Benzoates; Complement Activation; Complement Inactivating Agents
    Categories: Adverse Effects; Drug Therapy; Complications; Prevention & Control; Therapeutic Use; Chemically Induced
    Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS. (2020)
    Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantation. (2014)

  17. Chaturvedi, Shruti   Medical Oncology  Google Publications
    Division of Hematology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.
    Physician 
    Disclosed payments in 2021 from 9 biomedical companies, totalling $26,680, including $10,800 from  GENZYME CORPORATION
    Subjects: Thrombosis; Complement Activation; Endothelial Cells; Atypical Hemolytic Uremic Syndrome; Blood Platelets
    Categories: Diagnosis; Immunology; Metabolism; Blood; Complications; Cytology
    Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS. (2020)
    Diagnosis and management of the antiphospholipid syndrome. (2017)

  18. Espinosa, Gerard   Google Publications
    Department of Autoimmune Diseases, Hospital Clínic de Barcelona, Barcelona, Spain.
    Scientist  Highly Cited  Highly Published  Clinical Trial  Case Reports  Review 
    Subjects: Thrombosis; Antibodies, Antiphospholipid; Lupus Erythematosus, Systemic; Anticoagulants; Pregnancy Complications
    Categories: Immunology; Drug Therapy; Therapeutic Use; Epidemiology; Complications; Blood
    Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. (2015)
    Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry. (2016)

  19. Shoenfeld, Yehuda   Google Publications
    I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation Sechenov University, Russia.
    Scientist  Highly Cited  Highly Published  Case Reports  Review 
    Subjects: Antibodies, Antiphospholipid; Lupus Erythematosus, Systemic; Thrombosis; Beta 2-Glycoprotein I; Autoantibodies
    Categories: Immunology; Blood; Complications; Etiology; Diagnosis; Metabolism
    Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. (2015)
    Antiphospholipid syndrome. (2018)

  20. Matteson, Eric L   Rheumatology  Google Publications
    Mayo Clinic College of Medicine and Science, Rochester, MN. Top Hospital
    Physician 
    Disclosed payments in 2021 from 14 biomedical companies, totalling $11,878.31, including $7,148.75 from  Boehringer Ingelheim International GmbH
    Subjects: Endothelial Cells; Endothelium, Vascular
    Categories: Physiology; Epidemiology; Etiology
    The Epidemiology of Antiphospholipid Syndrome: A Population-Based Study. (2019)
    Antiphospholipid Syndrome: Role of Vascular Endothelial Cells and Implications for Risk Stratification and Targeted Therapeutics. (2017)

Note:
  1. Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);